Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
2010
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
2012
The RNA Binding Protein Quaking Regulates Formation of circRNAs
2015 Standout
Negative Regulation of Cytokine and TLR Signalings by SOCS and Others
2005
The renin–angiotensin system and cancer: old dog, new tricks
2010
Improving drug delivery to solid tumors: Priming the tumor microenvironment
2014
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
SOCS proteins, cytokine signalling and immune regulation
2007 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Wnt signaling in cancer
2016 Standout
WNT Signaling in Cancer Immunosurveillance
2018
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
2014
The biology and function of fibroblasts in cancer
2016 Standout
Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
2011
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
2011
Recombinant immunotoxins for the treatment of haematological malignancies
2004
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
2008
Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development
2011
Clinical cancer nanomedicine
2019
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target
2011
Extracellular matrix structure
2015 Standout
Cancer stem cells: In the line of fire
2012
Pyroptosis: mechanisms and diseases
2021 Standout
Insights from nanomedicine into chloroquine efficacy against COVID-19
2020 Standout
C-Reactive Protein, Interleukin 6 and Lung Cancer Risk: A Meta-Analysis
2012
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells
2013
Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
2012
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
SOCS regulation of the JAK/STAT signalling pathway
2008 Standout
Reactive oxygen species in cancer
2010 Standout
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Regulation of type I interferon responses
2013 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
2012
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
ROS signalling in the biology of cancer
2017 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer
2012
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Combining two strategies to improve perfusion and drug delivery in solid tumors
2013
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
The Role of Mechanical Forces in Tumor Growth and Therapy
2014
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
2016 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Total synthesis, biological evaluation of dendrodolides A–D and their analogues
2016
The Ultrastructure of Dyserythropoiesis in Aplastic Anaemia
1975
Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
2012
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer
2009
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
New mutations and pathogenesis of myeloproliferative neoplasms
2011
Marine natural products
2018 Standout
Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.
2014
Antibody–Enzyme Fusion Proteins for Cancer Therapy
2011
Immunotoxins for leukemia
2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence
2014
The evolving epigenome
2013
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
2013
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
2007
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
2017
Works of Edgar Jost being referenced
Epigenetic inactivation of secreted Frizzled‐related proteins in acute myeloid leukaemia
2008
Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro
2011
Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells
2013
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
2011
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR
2012
SOCS2: inhibitor of JAK2V617F-mediated signal transduction
2008
Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma
2009
Aberrant DNA methylation of the transcription factor C/EBPα in acute myelogenous leukemia
2008
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
2009
In vivo efficacy of the recombinant anti‐CD64 immunotoxin H22(scFv)‐ETA′ in a human acute myeloid leukemia xenograft tumor model
2010
CpG island methylation patterns in chronic lymphocytic leukemia
2009
DNA methylation changes in multiple myeloma
2004
Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
2008
Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
2003
Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders
2007
Proliferation Disturbances of Erythroblasts in Congenital Dyserythropoietic Anemia Type I and II
1971
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
2008